These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Bayer's response to "potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis". Piorkowski JD JAMA; 2004 Dec; 292(21):2655-7; discussion 2658-9. PubMed ID: 15572725 [No Abstract] [Full Text] [Related]
7. [Safety profile of statins]. Prieto JC Rev Med Chil; 2001 Nov; 129(11):1237-40. PubMed ID: 11836874 [TBL] [Abstract][Full Text] [Related]
8. Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy. Pogson GW; Kindred LH; Carper BG Am J Cardiol; 1999 Apr; 83(7):1146. PubMed ID: 10190540 [No Abstract] [Full Text] [Related]
9. Extending therapy options in treating lipid disorders: a clinical review of cerivastatin, a novel HMG-CoA reductase inhibitor. Stein EA Drugs; 1998; 56 Suppl 1():25-31; discussion 33. PubMed ID: 9740538 [TBL] [Abstract][Full Text] [Related]
10. Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin. Mantel-Teeuwisse AK; Klungel OH; Egberts TC; Verschuren WM; Porsius AJ; de Boer A Drug Saf; 2004; 27(1):63-70. PubMed ID: 14720086 [TBL] [Abstract][Full Text] [Related]
12. HMG CoA reductase-inhibitor-related myopathy and the influence of drug interactions. Huynh T; Cordato D; Yang F; Choy T; Johnstone K; Bagnall F; Hitchens N; Dunn R Intern Med J; 2002; 32(9-10):486-90. PubMed ID: 12380704 [TBL] [Abstract][Full Text] [Related]
14. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. Chang JT; Staffa JA; Parks M; Green L Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925 [TBL] [Abstract][Full Text] [Related]
15. The withdrawal of Baycol (cerivastatin). Griffin JP Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):177-80. PubMed ID: 11770168 [No Abstract] [Full Text] [Related]
16. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction. Kind AH; Zakowski LJ; McBride PE WMJ; 2002; 101(7):53-6. PubMed ID: 12426921 [TBL] [Abstract][Full Text] [Related]
17. By the way, doctor...I read about Baycol, the cholesterol-lowering drug being taken off the market because it caused fatal muscle damage. I don't take it, but I do take another statin. Should I be worried? Lee TH Harv Health Lett; 2001 Nov; 27(1):8. PubMed ID: 11724700 [No Abstract] [Full Text] [Related]
18. Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis. Psaty BM; Furberg CD; Ray WA; Weiss NS JAMA; 2004 Dec; 292(21):2622-31. PubMed ID: 15572720 [TBL] [Abstract][Full Text] [Related]
19. Analysis of German package inserts. Fuchs J; Hippius M; Schaefer M Int J Clin Pharmacol Ther; 2006 Jan; 44(1):8-13. PubMed ID: 16425965 [TBL] [Abstract][Full Text] [Related]
20. A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia. Sasaki J; Arakawa K; Yamamoto K; Kobori S; Ageta M; Kono S Clin Ther; 1998; 20(3):539-48. PubMed ID: 9663369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]